Western Australia's defence sector has taken centre stage at Avalon 2025 – the largest aerospace and defence expo in the ...

Scam prevention platform startup Charm Security Ltd. launched today with an announcement that it has raised $8 million in ...

BURLINGAME, Calif. (AP) — BURLINGAME, Calif. (AP) — Corvus Pharmaceuticals Inc. (CRVS) on Tuesday reported a loss of $12.1 million in its fourth quarter. The Burlingame, California-based ...

Honeywell's SwiftDecoder software powers Corvus Robotics' autonomous inventory management system, enhancing warehouse ...

Insiders who purchased Corvus Pharmaceuticals, Inc. (NASDAQ:CRVS) shares in the past 12 months are unlikely to be deeply impacted by the stock's 16% decline over the past week. After taking the ...

Corvus Pharmaceuticals highlighted significant progress for soquelitinib, including ongoing Phase 3 trials for T-cell lymphoma and advancements in atopic dermatitis studies. The company has ...

Miller, M.D., co-founder, president and chief executive officer of Corvus. "Our Phase 1 clinical trial in atopic dermatitis is nearing completion of enrollment in the third cohort at a dose level that ...

VANCOUVER, British Columbia, March 06, 2025 (GLOBE NEWSWIRE) — Scarlet Security & Risk Group (SSRG) further advances its vision of adding value in more ways in more places, by its majority ...

(RTTNews) - Corvus Pharmaceuticals, Inc.(CRVS), a clinical-stage biopharmaceutical company, Thursday reported positive data from its Phase 1/1b study of soquelitinib for the treatment of patients ...

Corvus Pharmaceuticals ...